- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glomerulonephritis in New Zealand
Total 143 results
-
Bristol-Myers SquibbTerminatedLupus NephritisUnited States, Taiwan, Spain, United Kingdom, Netherlands, Germany, China, Australia, Belgium, Mexico, Korea, Republic of, Czechia, Russian Federation, Israel, Canada, Italy
-
University of MichiganCompletedFocal Segmental Glomerulosclerosis | Minimal Change Disease | FSGS | MCDUnited States
-
Mallinckrodt ARD LLCCompletedIdiopathic Focal Segmental GlomerulosclerosisUnited States, Argentina, Turkey, Peru, Australia, Chile, Mexico
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedLupus Erythematosus, Systemic | Lupus NephritisUnited States, Mexico
-
Vera Therapeutics, Inc.SuspendedLupus Nephritis (LN)United States, Puerto Rico, Spain
-
Boehringer IngelheimCompletedLupus NephritisSpain, United Kingdom, United States, Canada, Thailand, Germany, Italy, Japan, Serbia, Australia, Korea, Republic of, Mexico, Malaysia, Philippines, Poland, Portugal, Greece, Hong Kong, Czechia, France
-
Aurinia Pharmaceuticals Inc.CompletedLupus NephritisUnited States, Argentina, Belarus, Brazil, Bulgaria, Canada, Chile, Colombia, Costa Rica, Croatia, Dominican Republic, Guatemala, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, North Macedonia, Peru, Philippines, Poland, Puerto Rico and more
-
Boehringer IngelheimCompletedLupus NephritisUnited Kingdom, Thailand, Germany, Japan, United States, Australia, Korea, Republic of, Hong Kong, Poland, Greece, Mexico, Czechia, Canada, Malaysia, Philippines, Portugal
-
Janssen Research & Development, LLCCompletedLupus NephritisUnited States, Belgium, Mexico, Poland, Netherlands, Thailand
-
Bristol-Myers SquibbTerminatedLupus NephritisAustralia, China, Italy, Taiwan, Turkey, United States, Hong Kong, Spain, Russian Federation, Korea, Republic of, Japan, Israel, Romania, Puerto Rico, Argentina, Brazil, Canada, Chile, Colombia, Czechia, India, Mexico, Peru
-
TakedaActive, not recruitingGlomerulonephritis | Kidney DiseaseTaiwan, Australia, Hungary, Spain, United Kingdom, United States, China, Korea, Republic of, Italy, Japan, Singapore
-
Bristol-Myers SquibbCompletedFocal Segmental Glomerulosclerosis | Nephrotic Syndrome | Minimal Change DiseaseUnited States
-
BiogenTerminatedLupus NephritisBelgium, Peru, Italy, Malaysia, Australia, Argentina, United States, Hong Kong, Hungary, Poland, Colombia, Russian Federation, Philippines, Brazil, France, Korea, Republic of, Mexico, Spain, Thailand
-
TakedaTerminatedLupus NephritisUnited States, France, United Kingdom, Germany, Spain, Russian Federation, Italy
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedA Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus NephritisLupus NephritisUnited States, Canada, France, Russian Federation, United Kingdom
-
EquilliumBiocon LimitedCompletedLupus Nephritis | Lupus ErythematosusUnited States, India, Poland
-
Travere Therapeutics, Inc.CompletedFocal Segmental GlomerulosclerosisUnited States, Italy, Czechia
-
BiogenTerminatedLupus NephritisUnited States, Peru, Belgium, Italy, Philippines, Malaysia, Hong Kong, Argentina, Germany, Hungary, Australia, Colombia, Russian Federation, Portugal, Mexico, Korea, Republic of, France, Thailand, Brazil, Poland, Spain
-
La Jolla Pharmaceutical CompanyTerminatedLupus Erythematosus, Systemic | Lupus NephritisTaiwan, United States, Belarus, Serbia, Czech Republic, Philippines, Lebanon, India, Korea, Republic of, Argentina, Australia, Brazil, Bulgaria, Georgia, Germany, Hong Kong, Hungary, Indonesia, Italy, Malaysia, Mexico, Poland, Portugal and more
-
Cabaletta BioRecruitingSystemic Lupus Erythematosus | Lupus NephritisUnited States
-
Aurinia Pharmaceuticals Inc.CompletedLupus NephritisUnited States, Bangladesh, Belarus, Bulgaria, China, Ecuador, Georgia, Guatemala, Korea, Republic of, Mexico, Philippines, Poland, Russian Federation, Serbia, Singapore, Spain, Sri Lanka, Taiwan, Thailand, Ukraine
-
Hoffmann-La RocheAspreva PharmaceuticalsCompletedLupus NephritisBelgium, Germany, Italy, Spain, Canada, France, Portugal, United States, Greece, Mexico, United Kingdom, Australia, China, Hungary, Argentina, Brazil, Czech Republic
-
Travere Therapeutics, Inc.RecruitingFocal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | Minimal Change Disease | Alport Syndrome | IgA VasculitisUnited States, Italy, Netherlands, Poland, Spain, United Kingdom, Germany, Sweden
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - World Health Organization (WHO) Class III | Lupus Nephritis - WHO Class IVUnited States
-
Prof. Dr. Paul BrinkkoetterGerman Research Foundation; Medical Faculty and the Faculty of Natural Sciences... and other collaboratorsRecruitingGlomerulosclerosis, Focal Segmental | Minimal Change Disease | Idiopathic Nephrotic SyndromeGermany
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedLupus NephritisUnited States, Korea, Republic of, Spain, Mexico, Philippines, Thailand, France, Germany, Belgium, Hong Kong, Taiwan, Canada, China, Argentina, United Kingdom, Brazil, Colombia, Czechia, Hungary, Netherlands, Russian Federation
-
Goldfinch Bio, Inc.TerminatedDiabetic Nephropathies | Glomerulosclerosis, Focal Segmental | Minimal Change DiseaseUnited States
-
PfizerTerminatedFocal Segmental Glomerulosclerosis (FSGS)United States, Spain, Czechia, Canada, France, Germany, United Kingdom, Poland, Japan, Mexico, Italy, Slovakia
-
Kezar Life Sciences, Inc.RecruitingLupus NephritisUnited States, Korea, Republic of, Australia, Malaysia, Taiwan, South Africa, Singapore, United Kingdom, Puerto Rico, Croatia, India, Greece, Spain, Brazil, Philippines, Guatemala, Argentina, Portugal
-
Hoffmann-La RocheGenentech, Inc.RecruitingLupus NephritisUnited States, Brazil, Canada, France, Italy, Peru, Poland, South Africa, Spain, United Kingdom, Mexico, Russian Federation
-
AstraZenecaRecruitingLupus NephritisChina, United States, Hungary, Germany, Italy, Belgium, India, Mexico, Vietnam, Argentina, Bulgaria, Colombia, Japan, Turkey, Taiwan, Thailand, France, Netherlands, Brazil, Malaysia, Peru, Poland, Russian Federation
-
Novartis PharmaceuticalsTerminatedLupus NephritisCzechia, Australia, Spain, Thailand, Brazil, Portugal, Vietnam, Korea, Republic of, Colombia, Guatemala, Slovakia, Philippines, Japan
-
Hoffmann-La RocheActive, not recruitingLupus NephritisUnited States, Italy, Argentina, Germany, Colombia, South Africa, Poland, United Kingdom, Russian Federation, Brazil, France, Peru, Spain, Israel, Mexico
-
Chinook Therapeutics U.S., Inc.Active, not recruitingDiabetic Kidney Disease | Focal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | IgA Nephropathy | Diabetic Nephropathy Type 2 | Alport SyndromeUnited States, Spain, Korea, Republic of, Australia, Italy, United Kingdom
-
Janssen Research & Development, LLCTerminatedLupus NephritisUnited States, Taiwan, Mexico, Spain, Russian Federation, Thailand, Poland, Argentina, Ukraine
-
Kezar Life Sciences, Inc.CompletedSystemic Lupus Erythematosus | Lupus NephritisUnited States, Australia, Mexico, Russian Federation, Colombia, Peru, Poland, Ukraine
-
Goldfinch Bio, Inc.TerminatedKidney Diseases | Urologic Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Complications | Diabetic Nephropathies | Glomerulonephritis | Nephritis | Glomerulosclerosis, Focal Segmental | Nephrosis | Nephrosis, LipoidUnited States
-
Hoffmann-La RocheCompletedLupus NephritisUnited States, Colombia, Israel, Brazil, Argentina, Costa Rica, France, Italy, Mexico, Panama, Peru, Spain
-
Novartis PharmaceuticalsTerminatedLupus NephritisChina, Croatia, Czechia, Russian Federation, Turkey, Australia, Spain, Thailand, Argentina, United States, Denmark, Greece, Romania, Germany, Korea, Republic of, India, Brazil, Japan, Peru, Portugal, Italy, Taiwan, Vietnam, Norway, Colo... and more
-
Novartis PharmaceuticalsRecruitingLupus NephritisFrance, Spain, Israel, Turkey, United States, Germany, India, Hungary, Malaysia, Portugal, Brazil, China, Puerto Rico, Hong Kong, Mexico, Singapore
-
AmgenTerminatedLupus NephritisSpain, Brazil, Taiwan, Thailand, Croatia, Serbia, United States, Malaysia, Poland, Philippines, Argentina, Israel
-
Novartis PharmaceuticalsRecruitingLupus NephritisChina, United States, Spain, Germany, Korea, Republic of, Italy, Thailand, Hungary, Argentina, Brazil, Singapore, Taiwan, France, Vietnam, Malaysia, Lithuania, Canada, India, Colombia, Romania, United Kingdom, Czechia, Guatemala, Mexico, Eston... and more
-
Reata, a wholly owned subsidiary of BiogenCompletedFocal Segmental Glomerulosclerosis | IgA Nephropathy | Autosomal Dominant Polycystic Kidney | CKD Associated With Type 1 DiabetesUnited States